Fruchtman Yariv, Strauss Tzipora, Rubinstein Marina, Ben Harush Miriam, Revel-Vilk Shoshana, Kapelushmik Joseph, Paret Gideon, Kenet Gili
a Department of Pediatric Emergency Care and Pediatric Hematology Unit , Soroka Medical Center , Beer-Sheba , Israel , affiliated to the Ben Gurion University of the Negev , Beer Sheva , Israel.
b Thrombosis Unit, National Hemophilia Center , Safra Children's Hospital, Sheba Medical Center , Tel Hashomer, Israel.
Pediatr Hematol Oncol. 2015;32(7):505-10. doi: 10.3109/08880018.2015.1068896. Epub 2015 Oct 5.
Purpura fulminans (PF) is a very rare clinicopathologic skin disorder comprising dermal microvascular thrombosis associated with perivascular hemorrhage of multiple origins. It may occur as the presenting symptom of severe congenital deficiency of protein C (PC) or protein S (PS) during the newborn period, or later in life following oral anticoagulant therapy with vitamin K antagonists, or of sepsis that may be associated with disseminated intravascular coagulation. Treatment consists of anticoagulants and PC concentrates during acute episodes. We report our experience in the diagnosis and management of pediatric PF. The medical records of the 6 children aged 2-16 years (median: 5 years) who presented with PF to our tertiary care center between 1996 and 2013 were studied. The thrombophilia workup revealed either the presence of congenital homozygous PC deficiency, prothrombotic polymorphisms (factor V Leiden and FIIG20210A heterozygosity), acquired PC/PS deficiency, or no discernible thrombophilia. The skin necrosis resolved following conservative fresh-frozen plasma/anticoagulant therapy in 2 cases, whereas 3 children required interventional plastic surgery. The sixth case, a 10-year-old child with severe PC deficiency, heterozygous factor V Leiden, and FIIG20210A, received recombinant activated PC. PF in childhood is rare and has multiple etiologies. Understanding of the variable pathogenesis and risk factors will facilitate diagnosis and appropriate clinical management.
暴发性紫癜(PF)是一种非常罕见的临床病理皮肤疾病,其特征为真皮微血管血栓形成,并伴有多种原因引起的血管周围出血。它可能在新生儿期作为严重先天性蛋白C(PC)或蛋白S(PS)缺乏的首发症状出现,也可能在生命后期因使用维生素K拮抗剂进行口服抗凝治疗后发生,或者与可能伴有弥散性血管内凝血的败血症有关。急性发作期的治疗包括使用抗凝剂和PC浓缩物。我们报告了我们在小儿PF诊断和管理方面的经验。对1996年至2013年间在我们三级医疗中心就诊的6名年龄在2至16岁(中位数:5岁)的患有PF的儿童的病历进行了研究。血栓形成倾向检查发现存在先天性纯合子PC缺乏、促血栓形成多态性(因子V莱顿突变和FII G20210A杂合性)、获得性PC/PS缺乏,或未发现明显的血栓形成倾向。2例患者经保守的新鲜冷冻血浆/抗凝治疗后皮肤坏死得到缓解,而3名儿童需要进行介入性整形手术。第六例患者是一名10岁儿童,患有严重PC缺乏、杂合子因子V莱顿突变和FII G20210A,接受了重组活化PC治疗。儿童PF罕见且病因多样。了解其可变的发病机制和危险因素将有助于诊断和适当的临床管理。